Reports for IRBESARTAN

Ingredient

IRBESARTAN

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
AVAPRO 150MG TABLET Resolved 2022-01-21 2022-06-09 153358
AVAPRO 300MG TABLET Resolved 2019-02-08 2019-03-29 75171
AVAPRO 300MG TABLET Resolved 2019-07-16 2019-11-05 89476
AVAPRO 300MG TABLET Resolved 2019-11-29 2020-01-24 100061
AVAPRO 300MG TABLET Resolved 2020-03-12 2020-04-22 108533
AVAPRO 300MG TABLET Resolved 2021-12-02 2022-06-09 150376
AVAPRO 300MG TABLET Resolved 2022-08-02 2022-09-17 165911
AVALIDE 12.5MG 150MG TABLET Resolved 2018-12-20 2019-02-27 70230
AVALIDE 12.5MG 150MG TABLET Resolved 2019-10-09 2020-01-24 95800
AVALIDE 150MG 12.5MG TABLET Resolved 2021-01-28 2021-03-20 132678

Showing 11 to 20 of 247

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-IRBESARTAN 300MG TABLET Discontinued 2019-01-04 2019-01-04 71237
ACT IRBESARTAN/HCT Discontinued 2018-10-19 2018-10-19 65068
ACT IRBESARTAN/HCT Discontinued 2018-10-19 2018-10-19 65071
ACT IRBESARTAN/HCT Discontinued 2018-10-19 2018-10-19 65074
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548

Showing 21 to 26 of 26